ஹ்யாநவர் ஸ்டாக் பரிமாற்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹ்யாநவர் ஸ்டாக் பரிமாற்றம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹ்யாநவர் ஸ்டாக் பரிமாற்றம் Today - Breaking & Trending Today

APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share


Search jobs
29-Apr-2021
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share
DGAP-News: APONTIS PHARMA AG
/ Key word(s): IPO
29.04.2021 / 08:30
The issuer is solely responsible for the content of this announcement.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share ....

United States , United Kingdom , Sven Pauly , Sara Pinto , Karlheinz Gast , Hauck Aufh , German Federal Financial Supervisory Authority Bafin , Munich Stock Exchange , Dusseldorf Stock Exchange , United Kingdom Financial Services , Distribution Services , Virtx Exchange , Paragon Fund Ii Gmbh Co , Tradegate Exchange , Hanover Stock Exchange , Stuttgart Stock Exchange , Eurocac Stock Exchange , Mm Warburg Co , European Parliament , Chix Exchange , Frankfurt Stock Exchange Scale , Financial Services , Securities Of The Company , Frankfurt Stock Exchange , Mm Warburg , German Federal Financial Supervisory Authority Bundesanstalt ,

SYNLAB sets final offer price for IPO at EUR 18.00 per share


SYNLAB sets final offer price for IPO at EUR 18.00 per share
Search jobs
DGAP-News: Synlab AG
/ Key word(s): IPO
27.04.2021 / 22:50
 
Total offer volume of EUR 772 million, assuming full exercise of Greenshoe option
Offer price implies a total market capitalisation of EUR 4 billion and a total enterprise value of EUR 5.9 billion
Free float expected to amount to 19% of outstanding share capital, if Greenshoe option is fully exercised
First day of trading on the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange under the trading symbol SYAB is planned for Friday, 30 April 2021
SYNLAB (the Company ), the largest European clinical laboratory and medical diagnostic services company, has set the final offer price for its initial public offering (the Offering ) at EUR 18.00 per share. Assuming full exercise of the Greenshoe option and based on the final offer price, the total offer volume amounts to EUR 772 million. This compr ....

United States , District Of Columbia , United Kingdom , Bartl Wimmer , Mathieu Floreani , Sami Badarani , Munich Stock Exchange , Dusseldorf Stock Exchange , Company The Offering , Goldman Sachs , Deutsche Bank Aktiengesellschaft , Lilja Co , Distribution Services , Virtx Exchange , Goldman Sachs Bank Europe , Barclays Bank Ireland , European Union Withdrawal , Hanover Stock Exchange , Commission Delegated Directive , Stuttgart Stock Exchange , Eurocac Stock Exchange , Unicredit Bank , European Parliament , Bnp Paribas , Financial Services , Chix Exchange ,

Investegate |Synlab AG Announcements | Synlab AG: SYNLAB sets final offer price for IPO at EUR 18.00 per share


Disclaimer
This release is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan. It does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Japan. The shares mentioned herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the Securities Act ). The shares may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of shares of SYNLAB AG (the Company ) in the United States. ....

United States , District Of Columbia , United Kingdom , Mark Reinhard , Carolin Amann , Munich Stock Exchange , Dusseldorf Stock Exchange , Company The Offering , Deutsche Bank Aktiengesellschaft , Virtx Exchange , Goldman Sachs Bank Europe , Barclays Bank Ireland , European Union Withdrawal , Hanover Stock Exchange , Commission Delegated Directive , Stuttgart Stock Exchange , Eurocac Stock Exchange , Unicredit Bank , European Parliament , Bnp Paribas , Financial Services , Chix Exchange , Frankfurt Stock Exchange , Investment Bank , Berlin Stock Exchange , Trading Of The Company ,